Profits before Patients: The Johnson & Johnson Hypocrisy

While in US Johnson & Johnson agrees to compensate with $1 billion for the liability of its implants poisoning bloodstreams of patients, in India it is shedding all conscience.

The Dark Side of India’s Booming Pharma Industry

Recent warnings and crackdowns from US FDA and its Indian counterpart CDSCO have again brought the grave danger that adulterated and substandard products that pharma manufacturers are putting out in a largely unaware and uneducated market. HEAD SHOT USFDA recently reproached…